Safety and Tolerability of the Dual 5-Alpha Reductase Inhibitor Dutasteride in the Treatment of Androgenetic Alopecia.

Choi, Gwang Seong; Kim, Joon Hyung; Oh, Shin-Young; Park, Jung-Min; Hong, Ji-Soo; Lee, Yil-Seob; Lee, Won-Soo

Choi, Gwang Seong; Kim, Joon Hyung; Oh, Shin-Young; Park, Jung-Min; Hong, Ji-Soo; Lee, Yil-Seob; Lee, Won-Soo.

Afiliación

Choi GS; Department of Dermatology, Inha University College of Medicine, Incheon, Korea.
Kim JH; GlaxoSmithKline, Seoul, Korea.
Oh SY; GlaxoSmithKline, Seoul, Korea.
Park JM; GlaxoSmithKline, Seoul, Korea.
Hong JS; GlaxoSmithKline, Seoul, Korea.
Lee YS; GlaxoSmithKline, Seoul, Korea.
Lee WS; Department of Dermatology and Institute of Hair & Cosmetic Medicine, Yonsei University Wonju College of Medicine, Wonju, Korea.

Ann Dermatol ; 28(4): 444-50, 2016 Aug.

Article en En | MEDLINE | ID: mdl-27489426

Palabras clave

Alopecia; Drug-related side effects and adverse reactions; Dutasteride; Product surveillance; Safety; Treatment outcome; postmarketing

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Idioma: En Revista: Ann Dermatol Año: 2016 Tipo del documento: Article Pais de publicación:

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google